Skip to main content

Table 6 Types of GI tools within GI tool categories by guideline characteristics

From: Number and type of guideline implementation tools varies by guideline, clinical condition, country of origin, and type of developer organization: content analysis of guidelines

Guideline characteristic (n GI tools) GI tool categories and types (n, %)
Patient Clinician Implementation Evaluation
Total Information Self-management Guideline summary Total Guideline summary Algorithm Form or checklist Total Training material Resources Total Audit tool Measures
Overall 113 92 (81.4) 15 (13.3) 6 (5.3) 239 116 (48.5) 92 (38.5) 31 (13.0) 66 37 (56.1) 29 (43.9) 46 30 (65.2) 16 (34.8)
Condition
 Diabetes 37 31 (83.8) 3 (8.1) 3 (8.1) 64 35 (54.7) 18 (28.1) 11 (17.2) 20 12 (60.0) 8 (40.0) 9 6 (66.7) 3 (33.3)
 Stroke 26 23 (88.5) 2 (7.7) 1 (3.8) 63 40 (63.5) 13 (20.6) 10 (15.9) 8 3 (37.5) 5 (62.5) 3 3 (100.0) 0 (0.0)
 Heart failure 15 9 (60.0) 4 (26.7) 2 (13.3) 48 5 (10.4) 43 (89.6) 0 (0.0) 14 8 (57.1) 6 (42.9) 11 7 (63.6) 4 (36.4)
 Asthma 15 10 (66.7) 5 (33.3) 0 (0.0) 30 22 (73.3) 4 (13.3) 4 (13.3) 4 3 (75.0) 1 (25.0) 1 0 (0.0) 1 (100.0)
 Arthritis 12 12 (100.0) 0 (0.0) 0 (0.0) 13 5 (38.5) 8 (61.5) 0 (0.0) 6 1 (16.7) 5 (83.3) 4 2 (50.0) 2 (50.0)
 Depression 5 4 (80.0) 1 (20.0) 0 (0.0) 20 9 (45.0) 5 (25.0) 6 (30.0) 10 8 (80.0) 2 (20.0) 7 2 (28.6) 5 (71.4)
 Colorectal cancer 3 3 (100.0) 0 (0.0) 0 (0.0) 1 0 (0.0) 1 (100.0) 0 (0.0) 4 2 (50.0) 2 (50.0) 11 10 (90.9) 1 (9.1)
COUNTRY
 United States (199) 62 43 (69.4) 13 (21.0) 6 (9.7) 121 58 (47.9) 48 (39.7) 15 (12.4) 16 15 (93.8) 1 (6.3) 0 0 (0.0) 0 (0.0)
 United Kingdom (151) 28 26 (92.9) 2 (7.1) 0 (0.0) 38 6 (15.8) 32 (84.2) 0 (0.0) 41 15 (36.6) 26 (63.4) 44 28 (63.6) 16 (36.4)
 Canada (90) 21 21 (100.0) 0 (0.0) 0 (0.0) 60 43 (71.7) 4 (6.7) 13 (21.7) 8 6 (75.0) 2 (25.0) 1 1 (100.0) 0 (0.0)
 Australia (11) 1 1 (100.0) 0 (0.0) 0 (0.0) 9 5 (55.6) 2 (22.2) 2 (22.2) 0 0 (0.0) 0 (0.0) 1 1 (100.0) 0 (0.0)
 International (8) 1 1 (100.0) 0 (0.0) 0 (0.0) 7 3 (42.9) 4 (57.1) 0 (0.0) 0 0 (0.0) 0 (0.0) 0 0 (0.0) 0 (0.0)
 Singapore (3) 0 0 (0.0) 0 (0.0) 0 (0.0) 2 1 (50.0) 0 (0.0) 1 (50.0) 1 1 (100.0) 0 (0.0) 0 0 (0.0) 0 (0.0)
 Brazil (2) 0 0 (0.0) 0 (0.0) 0 (0.0) 2 0 (0.0) 2 (100.0) 0 (0.0) 0 0 (0.0) 0 (0.0) 0 0 (0.0) 0 (0.0)
 Finland (0) 0 0 (0.0) 0 (0.0) 0 (0.0) 0 0 (0.0) 0 (0.0) 0 (0.0) 0 0 (0.0) 0 (0.0) 0 0 (0.0) 0 (0.0)
 Spain (0) 0 0 (0.0) 0 (0.0) 0 (0.0) 0 0 (0.0) 0 (0.0) 0 (0.0) 0 0 (0.0) 0 (0.0) 0 0 (0.0) 0 (0.0)
Organization
 Government (166) 39 35 (89.7) 3 (7.7) 1 (2.6) 48 12 (25.0) 32 (66.7) 4 (8.3) 40 14 (35.0) 26 (65.0) 39 25 (64.1) 14 (35.9)
 Professional society (135) 23 15 (65.2) 3 (13.0) 5 (21.7) 97 41 (42.3) 48 (49.5) 8 (8.2) 13 11 (84.6) 2 (15.4) 2 1 (50.0) 1 (50.0)
 Disease foundation (66) 18 18 (100.0) 0 (0.0) 0 (0.0) 37 25 (67.6) 3 (8.1) 9 (24.3) 4 3 (75.0) 1 (25.0) 4 3 (75.0) 1 (25.0)
 Academic institution (63) 29 21 (72.4) 8 (27.6) 0 (0.0) 31 21 (67.7) 3 (9.7) 7 (22.6) 6 6 (100.0) 0 (0.0) 0 0 (0.0) 0 (0.0)
 Non-profit agency (33) 4 3 (75.0) 1 (25.0) 0 (0.0) 25 16 (64.0) 6 (24.0) 3 (12.0) 3 3 (100.0) 0 (0.0) 1 1 (100.0) 0 (0.0)
 International group (1) 0 0 (0.0) 0 (0.0) 0 (0.0) 1 1 (100.0) 0 (0.0) 0 (0.0) 0 0 (0.0) 0 (0.0) 0 0 (0.0) 0 (0.0)